TRVITrevi Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 22772
Ticker: TRVI
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2019-05-03
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: TRVI

Detail

Enriched 2026-08-14 20:47

Market cap: $2,526,096,660.93
Shares outstanding (class): 142,475,841
Shares outstanding (weighted): 142,475,841
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 34
Location: NEW HAVEN, CT
Homepage: https://www.trevitherapeutics.com
Description: Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Market cap and share counts drift.

Funds holding this security

83 funds · 83 positions · $175.09M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$44.13M	0.00%	3,699,063 NS	FIGI
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST	—	$31.28M	1.97%	2,622,306 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$27.80M	0.04%	2,330,547 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$13.86M	0.02%	1,162,130 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$9.32M	0.08%	780,836 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$7.26M	0.09%	608,481 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$5.90M	1.92%	494,432 NS	FIGI
iShares U.S. Pharmaceuticals ETF iShares Trust	IHE	$3.46M	0.35%	290,306 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$2.87M	0.24%	240,941 NS	FIGI
Small Cap Core Portfolio Bernstein Fund Inc	—	$2.71M	0.38%	227,140 NS	FIGI
VIP Health Care Portfolio Variable Insurance Products Fund IV	—	$2.15M	0.21%	180,000 NS	FIGI
Optimum Small-Mid Cap Growth Fund Optimum Fund Trust	—	$2.03M	0.27%	170,067 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.77M	0.04%	148,721 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.76M	0.00%	147,782 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$1.21M	0.03%	101,522 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERTRVI
FIGI_COMPOSITEBBG003QGQRB9
FIGI_SHARE_CLASSBBG003QGQRC8
CIK0001563880
ISINUS89532M1018
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: SIC 2834 indicates pharmaceutical preparations, so the security is an equity in the healthcare sector.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.